MALAT1 and type 2 diabetes mellitus: Expressions of several lncRNAs (ANRIL, LINC-PINT, MALAT-1, LIPCAR, SENCR, and MIAT) have been measured in T2D individuals with CVD complications and could predict these CVD events.